rethinkPeptides Search
Menu
Study breakdown

Brain Stress Receptors Maintain Blood Sugar During Starvation Through the Ghrelin System

AnimalModerate evidence
The takeaway

Central CRF receptor signaling maintains blood glucose during severe calorie restriction by activating the sympathetic nervous system to stimulate ghrelin secretion, revealing a brain-gut peptide axis for metabolic survival.

Brain → gut → glucose rescue

CRF receptors in the brain activate the sympathetic nervous system to release ghrelin from the stomach, which maintains blood sugar during starvation — a complete brain-gut peptide survival axis

What the researchers found

Central CRF-R signaling → sympathetic activation → ghrelin secretion → plasma glucose maintenance during 60% calorie restriction. Blocking CRF-R, beta-1 receptors, or ghrelin receptors all reduced glucose. Ghrelin co-administration rescued glucose in each case.

Why it matters

Understanding how the brain coordinates metabolic survival responses through peptide hormone cascades is fundamental to treating hypoglycemia, eating disorders, and metabolic crises. It also reveals why severe dieting can be metabolically dangerous.

The numbers in context

60% calorie restriction; CRF receptor activation raised ghrelin; atenolol blocked ghrelin elevation; ghrelin rescued glucose drops from CRF or beta-1 blockade

How the study worked

Animal study. Intracerebroventricular injections of urocortin-1, urocortin-2, and CRF-R antagonist in mice. 60% calorie restriction model. Ghrelin receptor antagonist (d-Lys3-GHRP-6) and atenolol treatment. Plasma ghrelin and glucose measurements. Rescue experiments with ghrelin co-administration.

Who was studied

Male C57BL/6 mice under 60% calorie restriction

What this study cannot tell us

Mouse model with extreme calorie restriction (60%). CRF-R and ghrelin pathways may function differently under more moderate dietary restriction. ICV injection is not clinically translatable. Chronic effects not assessed.

How to read the evidence

Moderate evidence: well-designed mechanistic study with multiple blockade and rescue experiments confirming each step of the signaling cascade.

When this study was published

Published 2021. The CRF-ghrelin axis continues to be studied for its role in stress-related metabolic disorders.

The bigger picture

This maps a complete brain-to-gut peptide signaling cascade for metabolic survival. The CRF-ghrelin axis connects psychological stress physiology to metabolic regulation, explaining how severe stress and starvation affect blood sugar control.

Questions still open

  • Does this CRF-ghrelin axis explain hypoglycemia in anorexia nervosa patients?
  • Could ghrelin supplementation prevent dangerous blood sugar drops during severe illness or fasting?
  • Is this pathway disrupted in conditions where ghrelin levels are abnormally low?

Common questions

How does the body maintain blood sugar during starvation?
This study reveals a complete peptide signaling chain: brain stress receptors (CRF-R) detect the calorie deficit → activate the sympathetic nervous system → stimulate the stomach to release ghrelin → ghrelin acts on the liver and other tissues to maintain blood glucose levels.
Why is ghrelin important for survival?
Ghrelin is more than just a "hunger hormone." During severe calorie restriction, it's essential for preventing dangerous blood sugar drops. Without ghrelin signaling, mice in this study could not maintain adequate glucose levels — suggesting ghrelin is a metabolic survival signal.

Read the original research

The role of central corticotrophin-releasing factor receptor signalling in plasma glucose maintenance through ghrelin secretion in calorie-restricted mice.

Journal of neuroendocrinology, 33(3), e12961

Citation

Kimura, Risa; Kondo, Daisuke; Takemi, Shota; Fujishiro, Miyuki; Tsukahara, Shinji; Sakai, Takafumi; Sakata, Ichiro. (2021). The role of central corticotrophin-releasing factor receptor signalling in plasma glucose maintenance through ghrelin secretion in calorie-restricted mice.. Journal of neuroendocrinology, 33(3), e12961. https://doi.org/10.1111/jne.12961